 |
|
|
The Institutes for Diabetes Discovery offers pharmaceutical sponsors the latest biology, chemistry, and pharmacokinetic expertise resources available today. We have extensive experience in the discovery of drugs and therapeutics for diabetes and its complications. Housed in over 46,000 square feet, our facility has more than 60 research scientists involved in discovery research directed at small molecule drugs.
IDD's excellence in research is attributable not only to our expert scientific staff, but to IDD's commitment to providing our scientists with state-of-the-art instrumentation:
 |
300 MHz Varian NMR |
|
HPLC systems with MS and Diode Array Detectors |
|
Micromass Ultima Quad LC-MS/MS |
|
Micromass MALDI-TOF MS |
|
CEQ 2000 DNA Sequencer and FID |
|
IRORI Accutag |
|
TECAN
|
|
HP GC/MS
|
|
